Example: Heart Attack

Search clinical trials for: Hydroxyitraconazole

Total 261 results

NCT00588016

Completed

Concentration of Itraconazole Solution in Nasal Secretions

Conditions: Sinusitis
NCT02120677

Completed

Topical Itraconazole in the Treatment of Basal Cell Carcinoma

Conditions: Basal Cell Carcinoma
NCT03572049

Recruiting

Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole

Conditions: Fungal Infection
NCT03972748

Recruiting

Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.

Conditions: Basal Cell Carcinoma; Hedgehog Pathway
NCT00871728

Completed

Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules

Conditions: Onychomycosis, Toe
NCT03843060

Completed

A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers

Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT03920527

Recruiting

Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA

Conditions: Chronic Pulmonary Aspergillosis
NCT01108094

Completed

Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas

Conditions: Basal Cell Carcinoma (BCC); Skin Cancer
NCT03264079

Completed

Effect of Itraconazole on the Pharmacokinetics of Bardoxolone Methyl in Healthy Adults

Conditions: Healthy Volunteers
NCT02259010

Completed

A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Conditions: Advanced Solid Tumors; Relapsed/Refractory Lymphoma
NCT04090047

Completed

A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants

Conditions: Heathy Participants
NCT04018872

Recruiting

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Conditions: Esophagus Adenocarcinoma; Esophagus Squamous Cell Carcinoma; Gastroesophageal Junction Adenocarcinoma
NCT03821493

Completed

Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single-Dose of PF-06651600 in Healthy Participants

Conditions: Healthy Participants
NCT01409018

Completed

Pharmacokinetics of Itraconazole in Pediatric Cancer Patients

Conditions: Pediatric, Cancer
NCT03479411

Completed

Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma

Conditions: Asthma
NCT03086226

Unknown status

Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan

Conditions: Mycetoma
NCT03923010

Terminated

A Study of Itraconazole in the Management of Superficial Fungal Infections in India

Conditions: Mycoses
NCT00356915

Completed

Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.

Conditions: Onychomycosis
NCT02354261

Completed

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

Conditions: Basal Cell Carcinoma in Basal Cell Nevus Syndrome
NCT04627129

Completed

A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects

Conditions: Healthy Adult Subjects
NCT01823289

Completed

An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections

Conditions: Pulmonary Fungal Infection
NCT01021683

Completed

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Conditions: Hematologic Neoplasms; Neutropenia; Fever
NCT02621905

Completed

Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg

Conditions: Neutropenia
NCT01450683

Terminated

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Conditions: Prostate Cancer; Prostatic Neoplasms; Castrate-resistant Prostate Cancer (CRPC); Androgen-insensitive Prostate Cancer; Hormone-refractory Prostate Cancer; Metastatic Disease
NCT04712396

Not yet recruiting

A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

Conditions: Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)